Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 299 M312 M278 M292 M 1.18 B Research & development ———— — Operating income 669 M778 M475 M-76 M 1.85 B Non-Operating Income, Total 23 M5 M9 M9 M 46 M Interest expense, net of interest capitalized 143 M94 M92 M78 M 407 M Non-Operating Income, excl. Interest Expenses -121 M-89 M-85 M-70 M -365 M Unusual income/expense 1 M02 M1 M 4 M Pretax income 550 M693 M398 M-145 M 1.5 B Equity in earnings 1 M4 M6 M— — Taxes 122 M150 M100 M-27 M 345 M Non-controlling/minority interest -1 M-2 M0-2 M -5 M After tax other income/expense -32 M-18 M-57 M-26 M -133 M Net income before discontinued operations 429 M545 M298 M-116 M 1.16 B Discontinued operations ———— — Net income 429 M545 M298 M-116 M 1.16 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 429 M545 M298 M-116 M 1.16 B Basic earnings per share (Basic EPS) 0.780.990.53-0.21 2.09 Diluted earnings per share (Diluted EPS) 0.780.980.54-0.21 2.09 Average basic shares outstanding 553.1 M553.1 M553.1 M553.2 M — Diluted shares outstanding 553.1 M553.9 M553.6 M553.2 M — EBITDA 925 M1.05 B698 M-118 M 2.55 B EBIT 743 M856 M495 M-316 M 1.78 B Cost of revenue 2.25 B2.59 B2.08 B1.97 B 8.89 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 182 M192 M203 M198 M 775 M